Rhythm Pharmaceuticals, Inc. RYTM
835 filings, 2 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 73 events
- Nov 3, 2026 Planned sale David McGirr (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 21,810 shares, runs to Feb 7, 2027
- Nov 3, 2026 Planned sale Christophe Jean (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 10,000 shares, runs to Jul 17, 2027
- Nov 3, 2026 Planned sale Alastair Garfield (Chief Scientific Officer) adopted a 10b5-1 trading planreported in the 10-Q, runs to Feb 1, 2028
- Nov 3, 2026 Planned sale David Meeker (Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 300,000 shares, runs to Mar 15, 2027
- Nov 3, 2026 8-K Quarterly results8-K item 2.02
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Sep 14, 2026 Planned sale David Meeker (Director, Officer) gave notice of a planned sale of 50,000 shares worth about $5.2MForm 144, approximate sale date Sep 14, 2026, under a 10b5-1 plan adopted Jun 15, 2026
- Aug 31, 2026 Planned sale HUNTER SMITH (Officer) gave notice of a planned sale of 62,774 shares worth about $6.7MForm 144, approximate sale date Aug 31, 2026, under a 10b5-1 plan adopted May 13, 2026
- Aug 13, 2026 Planned sale Jennifer Kayden Lee (Officer) gave notice of a planned sale of 75,834 shares worth about $8.9MForm 144, approximate sale date Aug 13, 2026, under a 10b5-1 plan adopted May 14, 2026
- Aug 13, 2026 Planned sale JOSEPH J SHULMAN (Officer) gave notice of a planned sale of 5,079 shares worth about $597KForm 144, approximate sale date Aug 13, 2026, under a 10b5-1 plan adopted Dec 15, 2025
- Aug 13, 2026 Planned sale ALASTAIR GARFIELD (Officer) gave notice of a planned sale of 7,763 shares worth about $913KForm 144, approximate sale date Aug 13, 2026, under a 10b5-1 plan adopted May 14, 2026
- Aug 12, 2026 Planned sale YANN MAZABRAUD (Officer) gave notice of a planned sale of 57,000 shares worth about $6.4MForm 144, approximate sale date Aug 12, 2026, under a 10b5-1 plan adopted May 13, 2026
- Aug 11, 2026 Planned sale PAMELA CRAMER (Officer) gave notice of a planned sale of 11,406 shares worth about $1.3MForm 144, approximate sale date Aug 11, 2026, under a 10b5-1 plan adopted Dec 15, 2025
- Aug 10, 2026 Planned sale PAMELA CRAMER (Officer) gave notice of a planned sale of 3,520 shares worth about $407KForm 144, approximate sale date Aug 10, 2026, under a 10b5-1 plan adopted Dec 15, 2025
- Aug 4, 2026 Planned sale Hunter Smith (Company's Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 62,774 shares, runs to May 12, 2027
- Aug 4, 2026 Planned sale Yann Mazzabraud (Company's Executive Vice President, Head of International) adopted a 10b5-1 trading planreported in the 10-Q, up to 57,000 shares, runs to Aug 15, 2027
- Aug 4, 2026 Planned sale Alastair Garfield (Company's Chief Scientific Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,763 shares, runs to Feb 13, 2027
- Aug 4, 2026 Planned sale Jennifer Lee (Company's Executive Vice President, Head of North America) adopted a 10b5-1 trading planreported in the 10-Q, up to 76,201 shares, runs to Mar 1, 2027
- Aug 4, 2026 Planned sale David Meeker (Company's Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 300,000 shares, runs to Mar 15, 2027
- Aug 4, 2026 Planned sale Lynn Tetrault (member of the Company’s Board of Directors) ended a 10b5-1 trading planreported in the 10-Q, up to 55,000 shares
- Aug 4, 2026 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
- Aug 4, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 25, 2026 8-K Shareholder vote results8-K item 5.07
- Jun 22, 2026 Planned sale LYNN TETRAULT (Director) gave notice of a planned sale of 37,000 shares worth about $3.6MForm 144, approximate sale date Jun 22, 2026, under a 10b5-1 plan adopted Dec 15, 2025
- Jun 15, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- May 5, 2026 8-K Quarterly results8-K item 2.02
- May 5, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 3, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Mar 26, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 20, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 16, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 4, 2026 Planned sale CAMILLE L BEDROSIAN (Director) gave notice of a planned sale of 64,540 shares worth about $5.8MForm 144, approximate sale date Mar 4, 2026
- Mar 3, 2026 Planned sale CAMILLE L BEDROSIAN (Director) gave notice of a planned sale of 35,460 shares worth about $3.2MForm 144, approximate sale date Mar 3, 2026
- Mar 2, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Feb 26, 2026 Planned sale Jennifer Lee (Company's EVP, Head of North America) adopted a 10b5-1 trading planreported in the 10-K, up to 62,459 shares, runs to Oct 1, 2026
- Feb 26, 2026 Planned sale Joseph Shulman (Company's Chief Technical Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 66,910 shares, runs to Mar 12, 2027
- Feb 26, 2026 Planned sale Lynn Tetrault (member of the Company's Board of Directors) adopted a 10b5-1 trading planreported in the 10-K, up to 55,000 shares, runs to Sep 16, 2026
- Feb 26, 2026 Planned sale Pamela Cramer (Company's Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 52,617 shares, runs to Mar 15, 2027
- Feb 26, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · We may offer and sell the securities identified above, other than the 2,395,831 shares of common stock offered by the selling stockholders, or the securities, from time to time in one or more offerings.
- Feb 26, 2026 8-K Quarterly results8-K item 2.02
- Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 5, 2026 Planned sale HUNTER SMITH (Officer) gave notice of a planned sale of 18,406 shares worth about $2.0MForm 144, approximate sale date Feb 5, 2026, under a 10b5-1 plan adopted Feb 28, 2025
- Feb 4, 2026 Planned sale HUNTER SMITH (Officer) gave notice of a planned sale of 3,247 shares worth about $352KForm 144, approximate sale date Feb 4, 2026, under a 10b5-1 plan adopted Feb 28, 2025
- Jan 9, 2026 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
- Dec 19, 2025 8-K Director or officer change8-K item 5.02
- Dec 11, 2025 Planned sale PAMELA CRAMER (Officer) gave notice of a planned sale of 3,350 shares worth about $351KForm 144, approximate sale date Dec 11, 2025, under a 10b5-1 plan adopted Aug 7, 2025
- Dec 11, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Nov 20, 2025 Planned sale PAMELA CRAMER (Officer) gave notice of a planned sale of 3,350 shares worth about $346KForm 144, approximate sale date Nov 20, 2025, under a 10b5-1 plan adopted Aug 7, 2025
- Nov 7, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Nov 4, 2025 Planned sale Pamela Cramer (Company’s Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 29,566 shares, runs to Nov 1, 2026
- Nov 4, 2025 Planned sale Jennifer Kayden Lee (Company’s Executive Vice President, Head of North America) adopted a 10b5-1 trading planreported in the 10-Q, up to 62,459 shares, runs to Jun 1, 2026
- Nov 4, 2025 8-K Quarterly results8-K item 2.02
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Aug 5, 2025 8-K Quarterly results8-K item 2.02
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 11, 2025 8-K Other events8-K item 8.01
- Jul 10, 2025 Offering Sale of 2.1M new shares424B5 · We are offering 2,058,824 shares of our common stock.
- Jul 9, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Jun 26, 2025 8-K Bylaws or fiscal year changed, Shareholder vote results8-K items 5.03, 5.07
- May 7, 2025 Planned sale David McGirr (board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 65,431 shares, runs to Nov 7, 2025
- May 7, 2025 Planned sale Hunter Smith (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 121,185 shares, runs to May 30, 2026
- May 7, 2025 Planned sale David Meeker (Chairman, President, and Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 43,621 shares, runs to Nov 7, 2025
- May 7, 2025 Planned sale Christopher German (Corporate Controller and Chief Accounting Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,386 shares, runs to Jun 10, 2026
- May 7, 2025 8-K Quarterly results8-K item 2.02
- May 7, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 7, 2025 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 20, 2025 8-K Material agreement ended, Regulation FD disclosure8-K items 1.02, 7.01
- Feb 28, 2025 Planned sale Yann Mazabraud (EVP, Head of International) adopted a 10b5-1 trading planreported in the 10-K, up to 99,495 shares, runs to Nov 11, 2025
- Feb 28, 2025 Planned sale Pamela Cramer (Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 50,394 shares, runs to Mar 17, 2026
- Feb 28, 2025 8-K Other events8-K item 8.01
- Feb 28, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 26, 2025 8-K Quarterly results8-K item 2.02
- Jan 10, 2025 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 3, 2026 | 10-Q | Quarterly report |
| Nov 3, 2026 | 8-K | Quarterly results |
| Oct 13, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Sep 14, 2026 | 144 | Notice of planned insider sale |
| Sep 14, 2026 | 4 | Insider trade |
| Sep 1, 2026 | 4 | Insider trade |
| Aug 31, 2026 | 144 | Notice of planned insider sale |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 3 | New insider |
| Aug 17, 2026 | 4 | Insider trade |
| Aug 17, 2026 | 4 | Insider trade |
| Aug 14, 2026 | 4 | Insider trade |
| Aug 14, 2026 | 4 | Insider trade |
| Aug 13, 2026 | 144 | Notice of planned insider sale |
| Aug 13, 2026 | 144 | Notice of planned insider sale |
| Aug 13, 2026 | 144 | Notice of planned insider sale |
| Aug 12, 2026 | 144 | Notice of planned insider sale |
| Aug 11, 2026 | 144 | Notice of planned insider sale |
| Aug 10, 2026 | 144 | Notice of planned insider sale |
| Aug 4, 2026 | 10-Q | Quarterly report |
| Aug 4, 2026 | 8-K | Quarterly results, Regulation FD disclosure, Other events |
| Jul 2, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 8-K | Shareholder vote results |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 24, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 8-K | Regulation FD disclosure, Other events |
| May 29, 2026 | DEFA14A | Extra proxy material |
| May 20, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 5, 2026 | S-8 | Shares registered for employee plans |
| May 5, 2026 | DEFA14A | Extra proxy material |
| May 5, 2026 | 10-Q | Quarterly report |
| May 5, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | ARS | Annual report to shareholders |
| Apr 29, 2026 | DEF 14A | Proxy statement |
| Apr 3, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Apr 3, 2026 | 4 | Insider trade |
| Apr 3, 2026 | 4 | Insider trade |
| Apr 3, 2026 | 3 | New insider |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 26, 2026 | 8-K | Regulation FD disclosure, Other events |
| Mar 20, 2026 | 8-K | Regulation FD disclosure, Other events |
| Mar 16, 2026 | 8-K | Regulation FD disclosure, Other events |
| Mar 16, 2026 | 4 | Insider trade |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 4, 2026 | 144 | Notice of planned insider sale |
| Mar 4, 2026 | 4 | Insider trade |
| Mar 4, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 144 | Notice of planned insider sale |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 8-K | Regulation FD disclosure, Other events |
| Feb 26, 2026 | S-8 | Shares registered for employee plans |
| Feb 26, 2026 | 10-K | Annual report |
| Feb 26, 2026 | 8-K | Quarterly results |
| Feb 26, 2026 | S-3ASR | Shelf registration |
| Feb 19, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 17, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 12, 2026 | 4 | Insider trade |
| Feb 12, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 6, 2026 | 4 | Insider trade |
| Feb 5, 2026 | 144 | Notice of planned insider sale |
| Feb 4, 2026 | 144 | Notice of planned insider sale |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 4 | Insider trade |
| Jan 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 16, 2026 | S-8 | Shares registered for employee plans |
| Jan 9, 2026 | 8-K | Quarterly results, Regulation FD disclosure, Other events |
| Dec 19, 2025 | 8-K | Director or officer change |
| Dec 15, 2025 | 4 | Insider trade |
| Dec 11, 2025 | 144 | Notice of planned insider sale |
| Dec 11, 2025 | 8-K | Regulation FD disclosure, Other events |
| Nov 24, 2025 | 4 | Insider trade |
| Nov 20, 2025 | 144 | Notice of planned insider sale |
| Nov 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 12, 2025 | 4 | Insider trade |
| Nov 10, 2025 | 144 | Notice of planned insider sale |
| Nov 7, 2025 | 144 | Notice of planned insider sale |
| Nov 7, 2025 | 8-K | Regulation FD disclosure, Other events |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RYTM/export.csv") into a cell.